Nutrileads, Nizo food research and Friesland Campina win EFRO grant
June 7th 2017, Wageningen, The Netherlands.

NUTRILEADS B.V., a Dutch Nutrition & Health startup, together with NIZO food research (consortium leader) and Friesland Campina, has been awarded a €3,7 million EFRO project called CHALLENGE. The aims of the project are to develop new food ingredients that will support resistance to infections, as well as affordable and predictive research models in humans (Human Challenge Models).
Read more

Nutrileads closes series A round to advance the development of its lead nutritional ingredient supporting immune function
March 29th 2017, Wageningen, The Netherlands.

Dutch nutritional health ingredients startup NUTRILEADS B.V. today announces the successful closing of a Series A financing round with existing shareholders DSM VENTURING, PPM OOST, SHIFT INVEST and THUJA CAPITAL.
Read more

Nutrileads announces positive outcome proof of concept study in humans
November 24th 2016, Wageningen, The Netherlands.

NUTRILEADS B.V., a Dutch Nutrition & Health startup today announces the positive outcome of a proof of concept study in humans demonstrating that its lead ingredient IMPP-1 is safe, well tolerated and supports immune function in humans.
Read more

Nutrileads wins prestigious eurostars grant Img
November 21st 2016, Wageningen, The Netherlands.

NUTRILEADS B.V., a Dutch Nutrition & Health startup has won a prestigious Eurostars grant to support the development of its lead ingredient IMPP-1 for application in medical foods.
Nutrileads (as consortium leader) and 4 partners from the Netherlands, Germany and Finland have been awarded a € 2 million Eurostars project called NIMF. The consortium will develop Nutrileads’ proprietary ingredient Immune Modulatory Plant Polysaccharide-1 (IMPP-1) into a new ingredient for medical food products to fight impaired immune functioning as a result of malnutrition (particularly common in a variety of patient groups). Nutrileads is developing this ingredient, in addition to medical food products, also for other food applications like dietary supplements and functional food.
The NIMF project was the highest rated project with a Dutch participant, ranking 4th of 269 applications across all fields in Europe. Erik Dam, CBO of NutriLeads emphasizes: “The very positive evaluation of the NIMF project provides a further validation of the relevance of our proposition and the quality of our science, team and partners”.

NutriLeads receives an ‘innovatie voucher’ of the European Regional Development Fund to support a Proof of Concept trial in human volunteers

Brief summary of the supported project’ PoC trial’ (PROJ-00535): Nutrileads BV identifies and develops innovative food ingredients that have a positive health effect. Its lead ingredient IMPP-1 supports immune function and increases resistance to common infections. In this project, IMPP-1 obtained from a food crop is tested in a proof of concept study in human volunteers to determine tolerability and effectiveness. This is an important step in the further development of IMPP-1 as health promoting ingredient for application in dietary supplements, medical and functional foods.

NutriLeads announces collaboration with DSM Nutritional Products
May 26th 2016, Wageningen, The Netherlands

NutriLeads B.V. announces the signing of a collaboration agreement with DSM Nutritional Products for the further development of its lead ingredient.
Read more

NutriLeads closes seed financing round
November 18th 2015, Wageningen, The Netherlands

Dutch nutritional health ingredients startup NUTRILEADS B.V. today announces the successful closure of a seed financing round with an investment syndicate comprising DSM VENTURING, PPM OOST, SHIFT INVEST and THUJA CAPITAL.
Read more

NutriLeads presents at Foodvalley expo 2015
October 12th 2015

Ruud Albers, CEO of NutriLeads, will give a presentation at the Science2Business event at the Foodvalley expo 2015 in Wageningen on Monday October 12th 2015. The presentation titled ‘IMPP-1, a plant fiber that modulates immune function’ will be held in session 2: GI functioning in animal and human health.

Erik Dam joins the management team of NutriLeads
August 31st 2015

NutriLeads announces that Erik Dam will join its management team as Chief Business Officer. With his experience in pharma and (medical) foods including VP roles at Baxter and Danone, Erik brings critical experience in strategy, marketing, sales, finance and general management to the company. Ruud Albers, former R&D director at Unilever and CEO of NutriLeads, indicates “over the past months we found our expertise, networks and personalities to be complementary. I am honored by his confidence in the company and I am very pleased to welcome Erik on board of NutriLeads. With his experience NutriLeads is well positioned for the next phase of its development”
Read More

NutriLeads presents at Axon seminar on Functional & Medical Foods
September 26th 2014

Ruud Albers, CEO of NutriLeads, presents at the seminar on Functional & Medical Foods organized by Axon science based layers in Amsterdam. In this seminar focusing on the changing regulatory environment Ruud will talk about ‘how to prepare for the launch of a functional food/medical food in the current market’.

NutriLeads presents at 1st European Nutrition Capital Network meeting
May 5th 2014

NutriLeads is one of 13 companies selected from 30 submissions to present its business proposition at the 1st European Nutrition Capital Network meeting cohosted by the Nutrition Capital Network Nutrition Capital Network and Vitafoods in Geneva, Switzerland on May 5th 2014.
Meetings Archive

NutriLeads winner of Biobased investorsforum
March 11th 2014

The presentation of NutriLeads at the Biobased investersforum at the year event of the ‘kenniscentrum plantenstoffen’ was selected as the winning pitch and was awarded with a check of €7500 for the further development of the proposition.

NutriLeads and NIZO food research obtain a grant from the top sector AgriFoods
December 12th 2013

NutriLeads together with NIZO food research obtained a grant from the Dutch Topsector AgriFood. The Food and Nutrition Delta grants aim to stimulate collaboration between innovative SMEs in the Agro Food sector. The awarded proposal FNDM130003 “Development of a new bioactive from food crops (IMPP-1) into innovative medical foods for malnourished immune-compromised patients” rated 2nd out of 68 applications. This specific project will support NutriLeads and NIZO food research to further optimize the production process of IMPP-1 and to test its effectiveness in a range of preclinical models.

NutriLeads participates with strong international team in venture challenge
Fall 2013

NutriLeads participated in the fall 2013 edition of the Venture challenge with a strong multinational team comprising of Agnès Méheust , Annick Mercenier, Nicolas Rachinel, Jerry Wells and Ruud Albers. During the intense working sessions the team focused the initial business idea to create optimal customer value, refined the various presentations and had the opportunity to pitch for investors.
The Venture challenge & their legacy

NutriLeads’ founder lead author on publication on assessment and interpretation of immune function in nutrition trials
August 2013

Dr Ruud Albers, founder of NutriLeads, is lead author of a consensus paper published in the British Journal of Nutrition. The paper titled “Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health” is authored by fifteen experts from industry, academia and governments. The paper reflects the outcome of an activity commissioned by the International Life Sciences Institute Europe to provide further guidance on the assessment and interpretation of the modulation of immune functions due to nutrition in the general population.
British Journal of Nutrition

NutriLeads obtains know how and rights on IMPP-1
February 20th 2012

NutriLeads obtained from Unilever the rights to use the know how, material and IP rights on an ingredient that was shown to support immune function and increase resistance to common infections. NutriLeads aims to valorize the discovery that this active ingredient IMPP-1 can be obtained from specific food crops thus enabling sustainable and cost effective sourcing. NutriLeads will develop this proprietary ingredient for application in specialized food products for specific patient & consumer groups.